Skip to main content

Neumora Therapeutics, Inc. (NASDAQ: NMRA) Investor Securities Class Action Lawsuit 02/06/2025

  • If you purchased shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA), you have certain options and for certain investors are short and strict deadlines running. Deadline: April 7, 2025. NASDAQ: NMRA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 06, 2025 - An investor in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Neumora Therapeutics, Inc. in connection with certain allegedly false and misleading statements made in connection with Neumora’s September 2023 initial public offer...



You must register (for free) or login to view the entire case.